Sign in
Taking peopleNo phase

Midpoint Transverse Process to Pleura (MTP) Block vs Erector Spinae Plane (ESP) Block for Acute Herpes Zoster (HZ) Pain

Key facts

Who runs it
Tanta University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
90 people, planned
Started
1 Jul 2026
Expected to end
1 Jun 2027
Type of study
Interventional, 2 groups
Treatments tested
  • Midpoint transverse process to pleura block
  • Erector spinae plane block
Record updated
29 July 2026

Who can take part

Age
21 years to 60 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Age 21-60 years
  • Both sexes
  • American Society of Anesthesiologists (ASA) physical status I-II
  • Acute thoracic herpes zoster within 30 days of rash onset
  • Moderate to severe pain [numeric rating scale (NRS)≥4]

Who cannot take part

  • Coagulopathy or anticoagulant therapy
  • Previous thoracic surgery deformity
  • Infection at puncture site
  • Allergy to study drugs
  • Severe psychiatric illness or inability to assess pain
  • Chronic diseases as renal, hepatic, malignancy
  • Patients with chronic disease need analgesia
  • Refusal to participate
  • Uncontrolled Diabetic patient
  • Patients are coming for more than 3 months (after healing of rash)

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 21 and 60 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The aim of this study is to compare the analgesic efficacy and safety of ultrasound-guided midpoint transverse process block versus ultrasound-guided erector spinae plane block in patients suffering from thoracic herpes zoster pain.

The 2 groups in the trial

  • Group MTPOther group

    Patients will receive ultrasound-guided midpoint transverse process to pleura block using 10 mL 0.25% bupivacaine + 40 mg methylprednisolone.

    Treatment: Midpoint transverse process to pleura block

  • Group ESPOther group

    Patients will receive ultrasound -guided erector spinae plane block using 10 mL 0.25% bupivacaine + 40 mg methylprednisolone.

    Treatment: Erector spinae plane block

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Comparison Between Midpoint Transverse Process to Pleura (MTP) Block vs Erector Spinae Plane (ESP) Block for Acute Herpes Zoster (HZ) Pain
Criteria questions
Built from NCT07732556, who can take part
Record updated
29 July 2026